# Ethical, Legal, and Societal Implications of Machine Learning

The EBSCO permalink supplied with the assignment requires GCU library authentication, which is not available in this environment. I therefore cannot verify or download the particular record behind that link. The analysis below uses a verifiable, peer-reviewed machine-learning application; if the linked record is a required, different article, its bibliographic details and findings should be substituted before submission.

## 1. Article and machine-learning application

Esteva et al. (2017), “Dermatologist-level classification of skin cancer with deep neural networks,” is a peer-reviewed study in *Nature*. It applies a deep convolutional neural network (CNN) to classifying skin-lesion images. The article is available through PubMed Central. This is the article analyzed below; its availability as the specific EBSCO record in the assignment link could not be confirmed.

## 2. Salient points of the research

The researchers trained a CNN using 129,450 clinical images representing 2,032 skin diseases. They evaluated the system on two binary classification tasks: keratinocyte carcinomas versus benign seborrheic keratoses, and malignant melanomas versus benign nevi. For these image-based tasks, the model performed comparably to the dermatologists in the study. The results demonstrate the potential for deep learning to support skin-cancer screening, not that an image classifier can replace a clinician. The evaluation used curated images and does not by itself establish safety or effectiveness in routine care, across all patient groups, or with consumer smartphone photographs.

## 3. Alternative algorithms

Alternative approaches include a support-vector machine (SVM) or random forest trained on measured lesion features such as asymmetry, border, color, and diameter. These models can be less computationally demanding and may be easier to inspect, but depend on reliable feature extraction and may miss patterns learned directly from pixels by a CNN. Logistic regression could provide a simpler, more interpretable baseline, though its performance may be limited when relationships among image features are complex. Other CNN architectures or transfer-learning models could also be compared. A fair comparison would use the same patient-separated training and test data, independent external validation, clinically relevant sensitivity and specificity, calibration, and subgroup performance—not accuracy alone.

## 4. Legal, ethical, and societal implications

The study illustrates how a promising diagnostic tool can create interconnected risks. Legally, health-image collection and clinical deployment raise privacy, consent, medical-device, and liability questions. Ethically, biased data, opaque predictions, false reassurance, and overreliance could harm patients. Socially, the technology might extend specialist support to underserved areas, but uneven performance or unequal access could reinforce existing disparities. These are potential deployment implications; the retrospective study does not establish that the model was deployed in clinical care.

## 5. Legal implications

Skin photographs and associated health information can be sensitive and sometimes identifiable. Organizations must establish a lawful basis for collecting, retaining, sharing, and using those data, and must honor applicable consent, security, and privacy obligations. In the United States, HIPAA applies to covered entities and their business associates, not automatically to every technology company or health app; consumer health apps outside HIPAA may have obligations under the Federal Trade Commission’s Health Breach Notification Rule and other applicable laws [3, 4].

If software is marketed for diagnosing or directing treatment, its intended use and functionality may make it a regulated medical device; regulatory obligations depend on the product and circumstances [5]. A research result alone does not establish regulatory clearance. In clinical use, responsibility for a missed cancer or unnecessary biopsy could involve the developer, healthcare organization, and clinician, depending on their roles and applicable law. Clear validation, documentation, human review, and defined accountability reduce risk but do not settle liability in advance.

## 6. Ethical implications

**Fairness and safety:** A model can perform differently for groups or image conditions underrepresented in its training and evaluation data. If it misses lesions more often in some groups, it could worsen unequal care. Before deployment, developers should test representative populations, report subgroup limitations, monitor performance after release, and provide a route for clinical override.

**Privacy and autonomy:** Patients should understand how their images may be used, including whether they contribute to model training or are shared. Data should be protected and collected only as needed. A patient should not be led to believe that an experimental or unvalidated prediction is a confirmed diagnosis.

**Transparency and accountability:** Deep networks can be difficult to interpret. Clinicians and patients need clear information about intended use, limitations, and uncertainty. Human oversight must be meaningful: clinicians should be able to question or disregard a prediction, and organizations should investigate errors rather than treating the model as the responsible decision-maker. These principles accord with WHO guidance on autonomy, well-being, transparency, accountability, inclusion, and equity in health AI [6].

## 7. Societal implications

If properly validated and made accessible, image-classification tools could help triage patients where dermatology expertise is scarce and support earlier assessment. Conversely, unequal access to devices, connectivity, and follow-up care could leave the people most in need without benefit. Systems developed from narrow data may also distribute errors unevenly and erode trust in healthcare. Automation could change clinicians’ workflows and encourage overreliance, while uncritical adoption might divert resources from human care. Deployment should therefore be evaluated for real-world health outcomes, equitable access, and effects on clinician-patient relationships—not just model performance.

## 8. Why ethics is necessary in machine learning

Machine-learning systems learn patterns from data that reflect real-world choices, gaps, and inequalities. Their outputs can scale those patterns into consequential decisions, often without being easy to explain. Ethical review helps identify who benefits and who bears the risks; privacy and fairness testing protect people whose data and lives are affected; and transparency, human oversight, and accountability provide ways to contest and correct harmful results. Ethics must apply throughout data collection, design, evaluation, deployment, and monitoring—not only after harm occurs. NIST’s AI Risk Management Framework organizes this ongoing work around governing, mapping, measuring, and managing risk [7].

## 9. Christian worldview

A Christian worldview can support this analysis by grounding it in the dignity of every person (Genesis 1:27), the call to act justly and compassionately (Micah 6:8), and the responsibility to care for one’s neighbor (Luke 10:27). Applied to this research, those commitments mean treating patients as persons rather than data points, paying particular attention to communities at risk of being underrepresented, protecting confidential images, and ensuring that technology serves people rather than displacing accountable care. They also encourage stewardship: use machine learning where evidence shows it can help, disclose its limits honestly, and preserve human responsibility for consequential decisions.

## References

1. Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. *Nature, 542*, 115–118. https://doi.org/10.1038/nature21056. Full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC8382232/
2. The Holy Bible, New International Version. (2011). Genesis 1:27; Micah 6:8; Luke 10:27.
3. U.S. Department of Health and Human Services. HIPAA for professionals: Privacy. https://www.hhs.gov/hipaa/for-professionals/privacy/index.html
4. Federal Trade Commission. Complying with the FTC’s Health Breach Notification Rule. https://www.ftc.gov/business-guidance/resources/complying-ftcs-health-breach-notification-rule
5. U.S. Food and Drug Administration. Digital health: Software as a medical device (SaMD). https://www.fda.gov/medical-devices/digital-health-center-excellence/software-medical-device-samd
6. World Health Organization. (2021). *Ethics and governance of artificial intelligence for health*. https://www.who.int/publications/i/item/9789240029200
7. National Institute of Standards and Technology. (2023). *Artificial intelligence risk management framework (AI RMF 1.0)*. https://doi.org/10.6028/NIST.AI.100-1
